• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Does Early Redemption of 9.75% Notes Reframe Calumet's Balance Sheet Story (CLMT)?

    Simply Wall St·07/16/2026 04:47:44
    Listen to the news
    • In early July 2026, Calumet Specialty Products Partners, L.P. and Calumet Finance Corp. redeemed all of their outstanding US$100 million 9.75% Senior Notes due 2028 at 102.438% of principal, plus accrued and unpaid interest, following a full redemption notice sent to holders on 2 July 2026.
    • This decision to retire high‑coupon debt ahead of maturity highlights an effort to reshape the capital structure and interest burden as the business evolves.
    • We'll now explore how this early redemption of high-interest senior notes may influence Calumet's existing investment narrative around growth and leverage.

    Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.

    Calumet Investment Narrative Recap

    To own Calumet, you need to believe it can turn a complex, leveraged refinery and specialty products footprint into a steadier, cash‑generating renewables and specialty platform. The early retirement of US$100 million in 9.75% notes slightly eases interest costs but does not fundamentally change that the key near term catalyst is executing on renewables growth, while balance sheet risk and regulatory dependence remain central concerns.

    The most relevant recent development alongside this redemption is the January 2026 refinancing, when Calumet issued US$405 million of 9.75% Senior Notes due 2031 to take out other high‑coupon paper. Together with the extended ABL and term loan maturities to 2031, these moves frame the current catalyst as gradual refinancing and simplification of the capital stack, which could influence how much cash is available for projects like MaxSAF 150 and for further deleveraging.

    Yet for all the balance sheet progress, the real risk investors should be aware of is how exposed Calumet still is to shifting renewable fuel policy and...

    Read the full narrative on Calumet (it's free!)

    Calumet's narrative projects $5.1 billion revenue and $40.3 million earnings by 2028. This requires 8.0% yearly revenue growth and an earnings increase of about $493 million from -$452.8 million today.

    Uncover how Calumet's forecasts yield a $23.45 fair value, a 41% downside to its current price.

    Exploring Other Perspectives

    CLMT 1-Year Stock Price Chart
    CLMT 1-Year Stock Price Chart

    Some of the lowest analysts were only expecting about US$4.4 billion of revenue and US$59.6 million of earnings by 2029, so compared with the baseline narrative their view of regulatory risk and financing costs is far more pessimistic, and this latest debt redemption may either soften or reinforce that stance once everyone updates their models.

    Explore 2 other fair value estimates on Calumet - why the stock might be worth as much as 50% more than the current price!

    Reach Your Own Conclusion

    Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

    Ready To Venture Into Other Investment Styles?

    These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.